|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
232,105 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,471,016 |
|
|
Indirect Value
|
$4,283,565 |
|
|
Total
Shares |
3,393,580 |
|
|
Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-06-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,450 |
36,522 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-08-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
32 |
36,490 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-10-05 |
5 |
GD |
$0.00 |
$0 |
I/I |
150 |
36,340 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-10-09 |
5 |
GD |
$0.00 |
$0 |
I/I |
21 |
36,319 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-10-31 |
5 |
GD |
$0.00 |
$0 |
I/I |
215 |
36,104 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-12-10 |
5 |
GD |
$0.00 |
$0 |
I/I |
300 |
45,249 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-12-31 |
5 |
GD |
$0.00 |
$0 |
I/I |
137 |
45,112 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2008-06-17 |
5 |
GD |
$0.00 |
$0 |
I/I |
2,240 |
42,162 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2008-08-11 |
5 |
GD |
$0.00 |
$0 |
I/I |
150 |
42,012 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2009-03-13 |
5 |
GA |
$0.00 |
$0 |
I/I |
5,597 |
13,157 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2009-03-13 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,597 |
35,118 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2009-11-09 |
5 |
GD |
$0.00 |
$0 |
D/D |
160 |
3,840 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2010-02-26 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,028 |
16,185 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2010-02-26 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,028 |
46,545 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2011-02-07 |
5 |
GD |
$16.26 |
$52,032 |
I/I |
3,200 |
37,821 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2011-02-07 |
5 |
GA |
$16.26 |
$52,032 |
I/I |
3,200 |
19,385 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-11-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
9,718 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-03-07 |
4/A |
AS |
$42.50 |
$42,500 |
D/D |
(1,000) |
23,600 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-09-08 |
4/A |
AS |
$44.25 |
$106,687 |
I/I |
(2,411) |
10,996 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2022-01-04 |
4/A |
AS |
$43.02 |
$699,104 |
I/I |
(16,053) |
130,930 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Executive Vice President |
|
2003-11-24 |
4 |
OE |
$7.13 |
$42,750 |
D/D |
6,000 |
16,194 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-02-06 |
4 |
AS |
$20.05 |
$10,025 |
I/I |
(500) |
7,485 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-02-27 |
4 |
D |
$22.91 |
$16,060 |
I/I |
(701) |
12,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-02-27 |
4 |
OE |
$2.72 |
$16,061 |
I/I |
5,907 |
13,392 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-03-05 |
4 |
AS |
$25.30 |
$12,650 |
I/I |
(500) |
12,191 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|